A novel role of cannabinoids: Implication in the fever induced by bacterial lipopolysaccharide

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 3, 2007, Pages 1127-1133

  Benamar, Khalid ^a   Yondorf, Menachem ^a   Meissler, Joseph J ^a   Geller, Ellen B ^a   Tallarida, Ronald J ^a   Eisenstein, Toby K ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; BACTERIUM LIPOPOLYSACCHARIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL MODEL; FEVER; GRAM NEGATIVE BACTERIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; BINDING, COMPETITIVE; BODY TEMPERATURE; BORNANES; DISEASE MODELS, ANIMAL; FEVER; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; TETRAHYDROCANNABINOL;

EID: 33847119950     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.113159     Document Type: Article

References (40)

1. Abe M, Oka T, Hori T, and Takahashi S (2001) Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats. Brain Res 916:41-49.
2. Benamar K, Geller EB, and Adler MW (2002) Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats. J Pharmacol Exp Ther 303:375-378.
3. Benamar K, McMenamin M, Geller EB, Chung YG, Pintar JE, and Adler MW (2005) Unresponsiveness of mu-opioid receptor knockout mice to lipopolysaccharide-induced fever. Br J Pharmacol 144:1029-1031.
4. Benamar K, Xin L, Geller EB, and Adler MW (2000) Blockade of lipopolysaccharide-induced fever by a μ-opioid receptor-selective antagonist in rats. Eur J Pharmacol 401:161-165.
5. Berdyshev E, Boichot E, Corbel M, Germain N, and Lagente V (1998) Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci 63:PL125-PL129.
6. Blatteis CM (2006) Endotoxic fever: new concepts of its regulation suggest new approaches to its management. Pharmacol Ther 111:194-223.
7. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, et al. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor: I. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272:22330-22339.
8. Cabral GA and Marciano-Cabral F (2005) Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol 78:1192-1197.
9. Cabral GA and Pettit DA (1998) Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol 83:116-123.
10. Cartmell T, Poole S, Turnbull AV, Rothwell NJ, and Luheshi GN (2000) Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (Lond) 526:653-661.
11. Chai Z, Gatti S, Toniatti C, Poli V, and Bartfai T (1996) Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-1-deficient mice. J Exp Med 183:311-316.
12. Chaperon F and Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243-281.
13. Davies JA and Graham JD (1980) The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice. Psychopharmacology (Berl) 69:299-305.
14. Dogen MD, Patel S, Rudaya AY, Steiner AA, Szekely M, and Romanovsky AA (2004) Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor. Br J Pharmacol 143:1023-1032.
15. Dragic T, Litwin V, Allaway GP, Martin SR, Huang YX, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (Lond) 381:667-673.
16. Elmquist JK, Scammell TE, and Saper CB (1997) Mechanism of CNS response to systemic immune challenge: the febrile response. Trends Neurosci 20:565-570.
17. Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, and James I (2001) The role of central and peripheral cannabinoid 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92:91-100.
18. Galieque S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, LeFur G, and Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
19. Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, and Shohami E (1997) Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. J Pharmacol Exp Ther 283:918-924.
20. Godlewski G, Malinowska B, and Schlicker E (2004) Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats. Br J Pharmacol 142:701-708.
21. Harre EM, Roth J, Pehl U, Kueth M, Gerstberger R, and Hubschle T (2002) Selected contribution: role of IL-6 in LPS-induced nuclear STAT3 translocation in sensory circumventricular organs during fever in rats. J Appl Physiol 92:2657-2666.
22. Hori T, Nakashima T, Take S, Kaizuka Y, Mori T, and Katafuchi T (1991) Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27:309-313.
23. Howlett AC (1995) Pharmacology of cannabinoid receptors. Rev Pharmacol Toxicol 35:607-634.
24. Jansen EM, Haycock DA, Ward SJ, and Seybold VS (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res 575:93-102.
25. Klein TW, Newton C, and Friedman H (1998) Cannabinoid receptors and immunity. Immunol Today 19:373-381.
26. Kluger MJ, Kozak W, Leon LR, Soszynski D, and Conn CA (1995) Cytokines and fever. Neuroimmunomodulation 2:216-223.
27. Lake KD, Compton DR, Varga K, Martin BR, and Kunos G (1997) Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030-1037.
28. Moldrich G and Wenger T (2000) Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21:1735-1742.
29. Myers RD, Lopez-Valpuesta FJ, Minano FJ, Wooten M, Barwick VS, and Wolpe SD (1994) Fever and feeding in the rat: actions of intrahypothalamic interleukin-6 compared to macrophage inflammatory protein-1β (MIP-1β). J Neurosci Res 39: 31-37.
30. Ovadia H, Wohlman A, Mechoulam R, and Weidenfeld J (1995) Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat: relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 34:175-180.
31. Rawls SM, Cabassa J, Geller EB, and AdlerMW(2002) CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2-induced hypothermia. J Pharmacol Exp Ther 301:963-968.
32. Reche I, Fuentes JA, and Ruiz-Gayo M (1996) Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors. Eur J Pharmacol 318:11-16.
33. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Cogny C, Martinez S, Maruani J, Neliat G, Caput D, et al. (1994) SR141617A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
34. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, et al. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644-650.
35. Roche M, Diamond M, Kelly JP, and Finn DP (2006) In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids. J Neuroimmunol 181:57-67
36. Smith SR, Terminelli C, and Denhardt G (2000) Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J Pharmacol Exp Ther 293:136-150.
37. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, and Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
38. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science (Wash DC) 310:329-332.
39. Varga K, Lake K, Martin BR, and Kunos G (1995) Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279-283.
40. Varga K, Wagner JA, Bridgen DT, and Kunos G (1998) Platelet- and macrophagederived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12:1035-1044.